Monday, December 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for Doximity NYSE DOCS

Elaine Mendonca by Elaine Mendonca
March 15, 2024
in Breaking News
0
Finance_ stocks to buy
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

The latest data on Doximity (NYSE: DOCS) from the past quarter reveals a diverse range of opinions from analysts, ranging from bullish to bearish. Here is a breakdown of their recent ratings and any changes over the last 30 days compared to previous months:

– Total Ratings: Bullish (0), Somewhat Bullish (0), Indifferent (5), Somewhat Bearish (1), Bearish (0)
– Last 30 Days: Bullish (0), Somewhat Bullish (0), Indifferent (0), Somewhat Bearish (1), Bearish (0)
– 1 Month Ago: Bullish (0), Somewhat Bullish (0), Indifferent (1), Somewhat Bearish (0), Bearish (0)
– 2 Months Ago: Bullish (0), Somewhat Bullish (0), Indifferent (3), Somewhat Bearish (0), Bearish (0)
– 3 Months Ago: Bullish (0), Somewhat Bullish (0), Indifferent (1), Somewhat Bearish (0), Bearish (0)

Analysts have also provided 12-month price targets for Doximity, with an average target of $29.00, a high estimate of $32.00, and a low estimate of $25.00. This suggests a positive trend, with the current average target indicating a 16.0% increase from the previous average price target of $25.00.

Key actions from analysts include upgrades and changes in ratings, such as:

– Anne Samuel from JP Morgan upgraded the rating to Underweight with a price target of $25.00, up from $22.00.
– Michael Cherny at Leerink Partners initiated a Market Perform rating with a price target of $32.00.
– Jailendra Singh from Truist Securities upgraded the rating to Hold with a price target of $29.00, up from $28.00.
– Stan Berenshteyn at Wells Fargo upgraded the rating to Equal-Weight with a price target of $27.00, up from $25.00.
– Allen Lutz from B of A Securities upgraded the rating to Neutral with a price target of $32.00, up from $29.00.
– Allen Lutz from B of A Securities also upgraded the rating to Neutral with a price target of $29.00, up from $21.00.

These changes in ratings reflect analysts’ responses to market conditions and company performance, indicating adjustments in their recommendations based on recent developments.

DOCS Stock Shows Positive Momentum on March 15, 2024: Trading Above 200-Day Moving Average

On March 15, 2024, DOCS stock showed positive momentum as it traded in the middle of its 52-week range and above its 200-day simple moving average. The price of DOCS shares increased by $0.20 since the market last closed, representing a 0.72% rise. The stock opened at $27.76, which was $0.09 lower than its previous close. Overall, DOCS stock had a decent performance on March 15, 2024, with a slight increase in price and trading above its 200-day moving average. Investors will be keeping a close eye on the stock in the coming days to see if this positive momentum continues.

DOCS Stock Performance Analysis: Revenue Growth but Decline in Net Income

On March 15, 2024, investors were closely monitoring the stock performance of DOCS, a company that provides document management solutions. According to data from CNN Money, DOCS reported a total revenue of $419.05 million for the past year, which represented a 21.98% increase compared to the previous year. In the third quarter of the same year, the company generated $135.28 million in total revenue, marking a 19.08% increase from the previous quarter.

Despite the positive revenue growth, DOCS experienced a decline in net income over the past year. The company reported a net income of $112.82 million for the year, which represented a 15.34% decrease compared to the previous year. However, in the third quarter, DOCS saw a significant improvement in net income, with a reported figure of $47.96 million, marking a 56.71% increase from the previous quarter.

Earnings per share (EPS) also showed mixed results for DOCS. The company reported an EPS of $0.53 for the past year, which represented a 24.15% decrease compared to the previous year. However, in the third quarter, DOCS reported an EPS of $0.24, marking a substantial 63.39% increase from the previous quarter.

Overall, the stock performance of DOCS on March 15, 2024, reflected a mix of positive and negative indicators. Investors will continue to monitor the financial performance of DOCS closely to assess the company’s future prospects and potential for growth in the document management solutions industry.

Tags: DOCS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
OHI stock news

Olin Announces Dividend Payout and Maintains Consistent Dividend History

Westinghouse Air Brake CEOs Insider Sell Causes Share Price Dip

Analyst Increases Price Target for Madrigal Pharmaceuticals Maintains Strong Buy Recommendation

Recommended

JD.com Stock

Pivotal Week Ahead for JD.com as Major European Acquisition and EV Launch Converge

2 months ago
Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive’s Rogue Forecast

2 months ago
Fiserv Stock

Fiserv’s Strategic Expansion Meets Legal Scrutiny

3 months ago
Does_Walmart_Take_Google_Pay

Does Walmart Take Google Pay? Exploring Walmart’s Exclusive Payment Solution

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

Trending

Tesla Stock
Automotive & E-Mobility

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

by Dieter Jaworski
December 21, 2025
0

Tesla shares are trading near their 52-week high as the company approaches a pivotal week, fueled by...

Wolfspeed Stock

Wolfspeed Secures Financial and Strategic Milestones

December 21, 2025
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push
  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com